Skip to main content
AMB Express logoLink to AMB Express
. 2017 Feb 23;7:49. doi: 10.1186/s13568-017-0344-y

Thymol and carvacrol induce autolysis, stress, growth inhibition and reduce the biofilm formation by Streptococcus mutans

Shams Tabrez Khan 1,2,, Merajuddin Khan 3, Javed Ahmad 1,2, Rizwan Wahab 1,2, Omar H Abd-Elkader 2, Javed Musarrat 4, Hamad Z Alkhathlan 3,, Abdulaziz A Al-Kedhairy 1
PMCID: PMC5323333  PMID: 28233286

Abstract

Organic compounds from plants are an attractive alternative to conventional antimicrobial agents. Therefore, two compounds namely M-1 and M-2 were purified from Origanum vulgare L. and were identified as carvacrol and thymol, respectively. Antimicrobial and antibiofilm activities of these compounds along with chlorhexidine digluconate using various assays was determined against dental caries causing bacteria Streptococcus mutans. The IC50 values of carvacrol (M-1) and thymol (M-2) against S. mutans were 65 and 54 µg/ml, respectively. Live and dead staining and the MTT assays reveal that a concentration of 100 µg/ml of these compounds reduced the viability and the metabolic activity of S. mutans by more than 50%. Biofilm formation on the surface of polystyrene plates was significantly reduced by M-1 and M-2 at 100 µg/ml as observed under scanning electron microscope and by colorimetric assay. These results were in agreement with RT-PCR studies. Wherein exposure to 25 µg/ml of M-1 and M-2 showed a 2.2 and 2.4-fold increase in Autolysin gene (AtlE) expression level, respectively. While an increase of 1.3 and 1.4 fold was observed in the super oxide dismutase gene (sodA) activity with the same concentrations of M-1 and M-2, respectively. An increase in the ymcA gene and a decrease in the gtfB gene expression levels was observed following the treatment with M-1 and M-2. These results strongly suggest that carvacrol and thymol isolated from O. vulgare L. exhibit good bactericidal and antibiofilm activity against S. mutans and can be used as a green alternative to control dental caries.

Electronic supplementary material

The online version of this article (doi:10.1186/s13568-017-0344-y) contains supplementary material, which is available to authorized users.

Keywords: Thymol, Carvacrol, Oral hygiene, Alternative antimicrobials, S. mutans

Introduction

The oral cavity is a complex microbial environment hosting around 600 different bacterial species and many of these bacteria are now being associated with oral diseases (Dewhirst et al. 2010; Moore and Moore 1994; Wade 2013). Dental diseases incur substantial economic losses globally accounting to 298 billion US dollar per year which is 4.6% of the total global health expenditure (Listl et al. 2015). The evidence is also now available that the recurring infections of these oral microorganisms result in a number of systemic diseases further adding to the economic losses and loss of life (Khan et al. 2015; Li et al. 2000). One of the most important etiological agents of dental caries is Streptococcus mutans (Loesche 1986). In addition to being classically associated with dental caries, this bacterium also causes other systemic diseases such as ulcerative colitis, endocarditis and septicemia (Kojima et al. 2012; Nobbs 2016; Robbins et al. 1977; Tunkel and Sepkowitz 2002). The biofilm formation by S. mutans and its ability to promote the biofilm formation by other oral bacteria also makes it more difficult to treat the infections of S. mutans (Ahn et al. 2008; Klein et al. 2015; Krzyściak et al. 2014). Therefore, for a good oral hygiene, it is very important to control the growth of S. mutans in the oral cavity. Furthermore, the unwarranted and overuse of the antibiotics in dentistry has resulted in the drug resistance among commensal as well as pathogenic bacteria of the oral cavity including S. mutans (Leistevuo et al. 2000; Sweeney et al. 2004). Therefore, alternatives to conventional antimicrobial agents are highly and urgently required. Among, the alternative antimicrobials are engineered nanomaterials, plant-based materials, bacteriocins and phage-based therapies (Allen et al. 2014; Khan et al. 2016b, c; Rose et al. 2014).

Plant based materials, especially from edible plants, are an effective alternative antimicrobials especially those classified as GRAS (generally recognized as safe) (Burdock and Carabin 2004). Two such commonly used edible plants in traditional medicine since ancient times are Origanum and Thymus (Craig 1999; Nostro and Papalia 2012). Essential oils from these plants have been shown to exhibit significant antimicrobial activities and their antimicrobial activity against food-borne pathogens have been already tested (Chorianopoulos et al. 2004). The major components in the essential oils of Origanum and Thymus are the phenolic monoterpene carvacrol and its isomeric form Thymol (Chorianopoulos et al. 2004; Fachini-Queiroz et al. 2012). Both Carvacrol and Thymol have been classified as GRAS and their use in food has been approved by European Parliament and Council (Hyldgaard et al. 2012). The antimicrobial activity of thymol and carvacrol have been reported against foodborne pathogens such as Clostridium perfringens, Escherichia coli O157:H7 and Listeria innocua (Du et al. 2015; Guarda et al. 2011). The mechanism behind this antibacterial activity includes permeabilization and depolarization of the cytoplasmic membrane, by reducing the pH gradient across the cytoplasmic membrane. This reduction in pH gradient also adversely affects the proton motive force leading to the depletion of the intracellular ATP subsequently leading to cell death (Ultee et al. 2002; Xu et al. 2008). It is also concluded in the same study that the phenolic hydroxyl group of thymol and carvacrol plays an important role in its antimicrobial activity (Ultee et al. 2002).

In this paper, we report a detailed study on antimicrobial and antibiofilm activities of two natural compounds M-1 and M-2 isolated from O. vulgare L. Moreover, comparison of antimicrobial and antibiofilm activities of these two compounds with chlorhexidine digluconate a commercially used antiplaque compound and clove oil is also discussed in detail in this study.

Materials and methods

Plant material and isolation of essential oils

The aerial parts of O. vulager L. grown in two different agro-climatic conditions were collected from Saudi Arabia and Jordan in the month of March 2014 and identified by Dr. Jacob Thomas Pandalayil (a botanical taxonomist from the Herbarium Division, College of Science, King Saud University, Riyadh, KSA). Stems of O. vulgare L. aerial parts from Saudi Arabia and Jordan were separated and subjected to hydro-distillation separately in a conventional Clevenger-type apparatus for 3 h according to the methods described previously (2016) to give light yellow colour oils with oil yield of 0.40 and 0.24% respectively.

Bacterial strains and culture media

The culture of Streptococcus mutans ATCC 25175 was purchased from American Type Culture Collection (ATCC). Brain heart infusion broth (BHI; Mast Group, Bootle, UK) with 2% sucrose was used for routine culture. For longer preservation and storage, the strain was stored at −80 °C in 20% glycerol.

Antimicrobial activity of M-1 and M-2 against S. mutans

The antimicrobial activity of M-1 and M-2 were determined by two methods namely microdilution method and plate count method. For microdilution method, 90 µl of BHI broth with 2% sucrose was added to each well in a 96 well plate. M-1, M-2, and clove oil were added to final concentrations of 1000, 500, 250, 125, 62.5, 31.25, 15.6 and 0 µg/ml. While, as a positive control chlorhexidine digluconate was added to final concentrations of 10.0, 5.0, 2.5, 0.125, 0.0625, 0.031, 0.015 and 0 µg/ml. To these wells 10 µl of S. mutans ATCC 25175 cultures grown overnight in BHI broth were added. And the 96 well plate was incubated at 37 °C for 24 h.

For plate count assays M-1, M-2 and clove oil were added to tubes containing 5 ml BHI broth with 2% sucrose to final concentrations of 200, 100, 50 and 25 µg/ml. Aliquots of 500 µl from the cultures of S. mutans ATCC 25175 grown to log phase were added to these tubes. Chlorhexidine digluconate was added to final concentrations of 10.0, 5.0 and 0 µg/ml as a positive control. Tubes without any test compound were used as a control. The cultures were incubated at 37 °C on a shaker with 150 rpm for 12 h. Following incubation, appropriate dilutions of treated and untreated cells were spread on BHI agar plates. The plates were incubated at 37 °C for 3 d. Finally, colony-forming units (CFUs) were counted and recorded.

Assessing bacterial viability by MTT assay

The change in bacterial viability after treatment with test compounds was determined using MTT assay as described by Mshana et al. (1998) S. mutans ATCC 25175 was grown in BHI broth containing 25, 50, 100 and 200 µg/ml of M-1, M-2, and clove oil for 4–6 h at 37 °C. Cells grown with various concentrations of chlorhexidine digluconate (2.5, 5, 10 and 20 µg/ml) were taken as positive control. An aliquot of 40 µl from this culture was transferred to wells in 96 well plates in triplicates. Ten microliters of the MTT (Sigma, USA) solution in PBS (5 mg/ml, pH 7.0) was then added to each well containing bacterial cells. Plates were incubated at 37 °C for 4 h. Following incubation 50 µl of a lysis buffer (20% sodium dodecyl sulfate in 50% N, N-dimethylformamide; pH 4.7) was added to the wells and the plates were further incubated at 37 °C for overnight. Finally, the mixture in the wells was mixed by pipetting and Absorbance at 570 nm was measured using Multiskan microtitre plate reader (Multiskan Ascent, Labsystems, Finland).

Live and dead staining

Streptococcus mutans ATCC 25175 was grown either with 25 µg/ml of M-1, M-2, and clove oil or with 2.5 µg/ml of chlorhexidine digluconate for 8 h at 37 °C on a shaker. Following treatment with test compounds, cells were harvested by centrifugation at 900×g and were washed with PBS buffer once, and finally suspended again in sterile PBS buffer (pH 7.5). Live and dead staining was performed using LIVE/DEAD® BacLight™ Bacterial Viability Kit (Molecular Probes, Life technologies, USA) following the instructions of the manufacturer. Cells stained as above were observed under a fluorescence microscope (Nikon Eclipse 80i; Nikon Co., Japan) and cells appearing red and green in colour were recorded as dead and total cells, respectively. Ten fields were counted for each treatment and the percentage of dead cells was calculated by comparing the population of dead cells to total cells in the same field.

Quantitative assessment of biofilm formation

The standard protocol of Burton et al. (2007) was used to quantitate the inhibition of biofilm formation on 48 well polystyrene plates (Nunc, Denmark) in the presence of the test compounds. In each well 900 µl of sterile BHI medium and 100 µl of exponentially growing cells of S. mutans ATCC 25175 were added. M-1, M-2, and clove oil were added to final concentrations of 200, 100, 50 and 25 µg/ml. As a positive control chlorhexidine digluconate was added to a final concentration of 10, 5, 2.5 and 1.2 µg/ml. Cultures without any test compounds were taken as control. Plates were then incubated for 24 h at 37 °C. Following incubation medium and the floating cells were gently and completely removed using a micropipette. The biofilm at the bottom of the wells was gently washed with PBS buffer (pH 7.4) three times. Biofilms were stained with 0.4% crystal violet (500 µl) dye for 15 min at room temperature. Wells were washed gently 3 times with PBS buffer to remove unbound dye. The crystal violet retained by the biofilm was solubilized in 500 µl of 33% acetic acid. Finally, absorption was determined at 620 nm using a microtitre plate reader (Multiskan, Finland).

Scanning electron microscopy of biofilm inhibition

Biofilms on the surface of polystyrene plates were grown in the presence of test compounds as detailed above. For biofilm formation assay S. mutans was grown with 100 µg/ml of clove oil, M-1, and M-2. Culture medium was removed with the help of a micropipette and the biofilm was washed gently with PBS as described above. The biofilms were stained with the fumes of 1% OsO4 at room temperature for 3 h and were rinsed three times with milli-Q. Samples were completely dehydrated with series of ethanol (30, 50, 70, 80, 90, 95 and 100%) and these dehydrated samples were sputter coated with platinum using an SPI-Module line of modular sputter coater. Samples were then observed under Scanning electron microscope (JSM-6380; JEOL), at an accelerating voltage of 10-KV and a magnification of 10,000×. Ten fields for each sample were recorded and compared.

Quantitative real-time PCR

For quantitative real-time PCR six genes involved in cell death, oxidative stress and biofilm formation were used to assess the change in their expression level following the exposure to the test compounds. Genes targeted in this study include autolysin gene AtlA and AtlE like autolysin gene, involved in cell wall remodeling and cell autolysis (Ahn and Burne 2006; Ajdić et al. 2002). Other genes targeted in this study include general stress response genes, biofilm formation genes, Polyribonucleotide nucleotidyl transferase (PnpA), superoxide dismutase (SOD), ymcA and gtfB gene (Carabetta et al. 2013; Yamamoto et al. 2000). Primers used to target these genes are listed in Table 1. The effectiveness of the primers was checked by PCR amplification of the genes using the genomic DNA from S. mutans. Furthermore, the PCR products obtained from these primers were sequenced using the same primers to confirm the specific amplification of the target genes. Cells were grown in the presence of 15 µg/ml of clove oil, M-1 and M-2 for 12 h at 37 °C. While, S. mutans cells grown with 1 µg/ml of chlorhexidine digluconate was taken as positive control. Instructions of manufacturer was followed for the extraction of total RNA from treated and untreated cells using RNeasy protect bacteria mini Kit (catalogue no.74524, Qiagen,). The concentration of the extracted RNA was determined using Nanodrop 8000 spectrophotometer (Thermo-Scientific, USA). While, the integrity of the prepared RNA was visualized on 1% agarose gel using BioRads gel documentation system (Universal Hood II, BioRad). The synthesis of first strand cDNA was carried out from 1 µg of total RNA by using Ready-To-GoTM RT-PCR beads (GE Healthcare, UK) and the manufacturer’s protocol. For Real-time quantitative PCR (RT-PCRq) SYBR Green I Master (Roche Diagnostics, Switzerland) and Light Cycler® 480 (Roche Diagnostics, Switzerland) were used. Two microliters of the synthesized template cDNA was added to a final volume of 20 µl reaction mixture. The thermal regime used for Real-time PCR cycle included 10 min at 95 °C followed by 40 cycles involving denaturation at 95 °C for 15 s, annealing at 60 °C for 20 s and elongation at 72 °C for 20 s.

Table 1.

Primers used for RT-PCR in this study

S. no. Primer name Seq (5′–3′) Gene Product size (~bp)
1 AtlE_F agctggtcccaaaggaaatc AtlE 200
AtlE_R gcctgtgcccaataatcatc
2 AtlA_F ggtttggaggcatcaactgt AtlA 138
AtlA_R agttggttggatatacgcgg
3 Stress_F taagccttacggtgcctttg PnpA 200
Stress_R attaccaacatcgccatcgt
4 GtfB_F gccagccaatgttcatcttt gtfB 160
GtfB_R gaggcatttccccaaatgta
5 YmcA_F gcttttgcaggaacatgaca ymcA 188
YmcA_R tggctcgataatcttggaca
6 SodA39I_F trcaycatgayaarcaccat sodA 400
SodA39J_R arrtartamgcrtgytcccaracrtc
7 16S_895F crcctggggagtrcrg 16S rRNA 200
16S_1100R agggttgcgctcgttg

Statistical analysis

All the tests were performed in triplicate and the data were expressed as the mean ± standard error of at least three independent experiments. A unpaired t test of GraphPad software was used to calculate p values. p values that were considered significant for different tests are provided in the figure captions.

Results

Isolation and identification of major compounds M-1 and M-2 from essential oils

Essential oils obtained from the stems of O. vulgare L. grown in Saudi Arabia and Jordon were analyzed using NMR, GC–MS and GC–FID techniques (results to be published elsewhere) revealed that the composition of the two oils differed significantly. Saudi origanum oil was found to be carvacrol chemotype where carvacrol content was about 80% of the total oil composition. On the other hand, Jordanian origanum oil was identified as thymol chemotype in which the content of thymol was about 69% of the total oil composition. In order to isolate major components, essential oils of Saudi origanum and Jordanian origanum were subjected to preparative thin layer chromatography (pTLC) using chloroform (100%) as developing solvent to give pure compounds M-1 and M-2 from oils of Saudi origanum and Jordanian origanum respectively. The chemical structures of purified compounds M-1 and M-2 were identified as carvacrol and thymol, respectively on the basis of their GC–MS, GC-FID, 1H and 13C NMR analysis and by comparison of their spectral data with those of related compounds (Fig. 1).

Fig. 1.

Fig. 1

Chemical structure of carvacrol (M-1) and thymol (M-2) (refer to Additional file 1 for raw data)

Antimicrobial activity of test compounds by microdilution method

Antimicrobial activity was determined by using microdilution method. S. mutans was grown with 1000, 500, 250, 125, 62.5, 31, and 15 and µg/ml of clove oil, M-1, and M-2. Highest antimicrobial activity against S. mutans ATCC 25175 was observed with thymol (M-2), where almost no growth was observed with 125 µg/ml of M-2 or thymol. While for M-1or carvacrol complete inhibition of growth was observed with 250 µg/ml. Clove oil appeared to be the least effective in inhibiting the growth of S. mutans wherein even with 1000 µg/ml of concentration complete inhibition of the growth was not observed. Chlorhexidine digluconate which was used as a positive control inhibited the growth of S. mutans completely at a concentration of 10 µg/ml and was found to be almost twenty times more effective than carvacrol and thymol.

Antimicrobial activity of test compounds by dilution plating method

Cells of S. mutans were grown with 200, 100, 50 and 25 µg/ml of clove oil, M-1, and M-2 in BHI broth. Decrease in colony forming units with the increasing concentration of test compounds is shown in Fig. 2. Thymol (M-2) was found to be the most effective against S. mutans and reduced the population of the bacterium by 93%, at a concentration of 200 µg/ml. While carvacrol (M-1) also reduced the population of S. mutans by 91% at the same concentration. Clove oil was least effective and could only reduce the population of test bacterium by 33% with the same concentration. The positive control chlorhexidine digluconate reduced the population of S. mutans by 100% only at a concentration of 10 µg/ml. Clove oil, carvacrol, and thymol exhibited an IC50 values of 306, 65 and 54 µg/ml, respectively. While, chlorhexidine digluconate exhibited an IC50 value of only 4.9 µg/ml.

Fig. 2.

Fig. 2

Growth inhibition of S. mutans in the presence of clove oil (CO), carvacrol (M-1; CAR), thymol (M-2; THY), and chlorhexidine digluconate (CHD). The experiment was done in triplicate and values are presented as mean ± S.D error. Asterisk represents the p value <0.05 (refer to Additional file 1 for raw data)

Change in bacterial viability as determined by MTT assay

Streptococcus mutans was grown with 200, 100, 50 and 25 µg/ml of clove oil, M-1, and M-2 in BHI broth. The formazan formed was dissolved using the lysis solution and the colour was read using a Multiskan spectrophotometer. The change in the viability with different concentrations of the test compounds is shown in Fig. 3a. Thymol (M-2), carvacrol (M-1) and clove oil decreased the cellular activity by 87 ± 6, 74 ± 8 and 47 ± 7%, respectively at a concentration of 200 µg/ml (Fig. 3a). While, chlorhexidine digluconate decreased the cellular activity by 90 ± 7%, at a concentration of 10 µg/ml.

Fig. 3.

Fig. 3

The change in the viability of S. mutans when grown with clove oil (CO), carvacrol (M-1; CAR), thymol (M-2; THY), and chlorhexidine digluconate (CHD). a Shows percent change in the metabolic activity of S. mutans using MTT assay with various concentrations of test compounds. While b shows the percent population of dead and live cells as determined by Live/dead staining when grown with test compounds. The experiment was done in triplicate and values are presented as mean ± S.D error. Asterisk represents the p value <0.05. Dagger the concentration of CHD is 2.5, 5, 10 and 20 µg/ml (refer to Additional file 1 for raw data)

Change in bacterial viability as determined by dead/live staining

Live and dead staining was performed after S. mutans was grown with 25 µg/ml of carvacrol (M-1), thymol (M-2) and clove oil. While cells were also grown with 2.5 µg/ml of chlorhexidine digluconate as a positive control. Thymol (M-2), was found to be the most effective compound which resulted in the death of 42 ± 4% of the cells (Fig. 3b). Carvacrol (M-1) and clove oil resulted in the death of 39 ± 4 and 5 ± 2% of the cells at a concentration of 25 µg/ml. While the positive control chlorhexidine digluconate resulted in the death of 37 ± 3% of the cells at a concentration of 2.5 µg/ml. Figure 4 shows the BacLight staining for live and dead cells after treatment with test compounds. It is clear from the figure that in untreated controls cells appeared more dispersed and were found to be arranged in clusters. Whereas the cells treated with thymol, carvacrol and chlorhexidine appeared in short chains and show significantly low density.

Fig. 4.

Fig. 4

The change in the viability of S. mutans as determined by Live/dead staining when untreated (a, CONT), treated with 25 µg/ml of clove oil (b, CO), carvacrol (d, M-1) and thymol (e, M-2) and 2.5 µg/ml of chlorhexidine digluconate (c, CHD). Orange or red cells represent dead cells while green cells represent live cells (refer to Additional file 1 for raw data)

Quantitative and qualitative assay for biofilm inhibition

Crystal violet assay was used for the detection of the biofilm inhibition in the presence of test compounds. Biofilm decreased by 85 ± 7, 82 ± 6 and 66 ± 5% in the presence of 200 µg/ml of thymol (M-2), carvacrol (M-1) and clove oil, respectively (Fig. 5). While the positive control chlorhexidine digluconate reduced the biofilm formation by 87 ± 5% at a very low concentration of 10 µg/ml.

Fig. 5.

Fig. 5

Percent inhibition of the biofilm formation by S. mutans in the presence of test compounds. Values are presented are mean ± S.D error of three independent experiments. Dagger chlorhexidine digluconate was tested at a concentration of 2.5, 5, 10 and 20 µg/ml. Asterisk represents the p value <0.05 (refer to Additional file 1 for raw data)

For qualitative assessment, biofilms of S. mutans grown in 48 well plates in the presence of test compounds or without test compounds were observed under a scanning electron microscope as described in materials and methods. Untreated controls show uniform well grown and densely arranged bunches of cells (Fig. 6A), almost similar pattern was observed for the cells treated with clove oil (data not shown). On the contrary, the cells treated with thymol and carvacrol appeared as short chains with considerably reduced cell density. The cells grown with chlorhexidine show the least density of the cells. Moreover, cells treated with thymol, carvacrol, and chlorhexidine digluconate appeared lysed and deformed and are marked with arrows in Fig. 6 B, C.

Fig. 6.

Fig. 6

Qualitative assessment of S. mutans biofilms grown in the presence of test compounds. Control biofilms show high density of cells with homogeneous shape (A). While, cells treated with chlorhexidine digluconate (B), carvacrol (C) and thymol (D) show short chains of cells with many deformed and lysed cells marked by arrows (refer to Additional file 1 for raw data)

Real-time PCR analysis of the genes involved in cell death, stress and biofilm formation

Change in the expression of six genes namely autolysin like genes AtlE (N-acetylmuramoyl-l-alanine amidase type), and AtlA like genes, Polyribonucleotide nucleotidyl transferase as a marker of general stress (PnpA), superoxide dismutase gene (SOD), ymcA and gtfB genes was studied to check the cell death, general stress and biofilm formation activities. Since it was found that two genes PnpA like and AtlA like genes were not sufficiently amplified in PCR assay using genomic DNA from S. mutans as template, these two genes were not used in RT-PCR studies. Furthermore, the sequence of the PCR products amplified using the PCR primers confirms that these primers are specifically binding to the target genes (Additional file 1).

RT-PCR analysis shows an increase of 2.4, 2.2 and 1.3 folds in the expression of Autolysin gene AtlE when S. mutans was grown with 15 µg/ml of thymol (M-2), carvacrol (M-1) and clove oil, respectively (Fig. 7). This increase in the expression of AtlE gene suggests that exposure to thymol and carvacrol induces apoptosis-like activity. Similarly, when S. mutans was grown with the same concentration of thymol (M-2), carvacrol (M-1) and clove oil, the expression of ymcA gene was upregulated by 2.1, 1.7 and 1.2 folds, respectively. The expression level of sodA genes also increased by 1.43, 1.32, and 1.1 when grown with 15 µg/ml of thymol (M-2), carvacrol (M-1) and clove oil, respectively. An increase in the expression of these genes shows that exposure to thymol and carvacrol results in an increase in oxidative stress and general stress in S. mutans. On the contrary the expression level of gtfB decreased by 0.3, 0.3 and 0.1 folds, when grown with thymol (M-2), carvacrol (M-1) and clove oil, respectively. This decrease in gtfB gene expression suggests the inhibition of biofilm formation which was also observed in other experiments. Similar, trend was observed, with the positive control chlorhexidine digluconate wherein a 2.9, 3.3 and 2.1 folds increase in the expression of ymcA, autolysin AtlE, and sodA genes, respectively was observed at a concentration of 1 µg/ml. While the exposure to chlorhexidine digluconate resulted in 0.4 folds decrease in the expression of the gtfB gene.

Fig. 7.

Fig. 7

RT-PCR analysis of S. mutans grown with the test compounds targeting Autolysin AtlE, gtfB, sodA and ymcA genes. The expression of AtlE, sodA and ymcA genes was induced by the test compounds while, gtfB gene was downregulated (refer to Additional file 1 for raw data)

Discussion

Essential oils from edible plants especially those classified as GRAS are one of the safe alternatives to traditional antibiotics (Kalemba and Kunicka 2003). But the commercialization of these plant-based products is often hampered by the inability to purify bioactive compounds from these plants. Two such compounds, thymol, and carvacrol are the main constituents of O. vulgare L., both compounds are known to exhibit antimicrobial activity against a number of pathogens (Chorianopoulos et al. 2004; Thosar et al. 2013; Ultee et al. 2002). Interestingly, an in vitro study has demonstrated that thymol, and carvacrol show selectively higher antimicrobial activity against the tested pathogenic bacteria (Escherichia coli, Clostridium perfringens, and Salmonella) than the beneficial probiotic bacteria Lactobacillus (Du et al. 2015). When thymol and carvacrol were tested in vivo for their efficacy to inhibit C. perfringens in broilers it was found that although the population of the pathogen was not reduced significantly but the treatment alleviated intestinal lesions caused by these pathogens (Du et al. 2015). The same group (Du et al. 2016) in their in vivo study on broilers has further demonstrated many beneficial effects of thymol and carvacrol including an increase in feed conversion efficiency, increase in immunity against virus and tumor. It has been reviewed earlier also that herbs that serve as a primary source of these essential oils exhibit anticancer activities (Craig 1999). Hence, thymol and carvacrol in addition to possessing desired antimicrobial activity also have known health benefits making these essential oils a promising alternative antimicrobial agent.

Dental caries and periodontal diseases are most prevalent microbial diseases and S. mutans is one of the most important bacterium involved in dental caries (Loesche 1986; Selwitz et al. 2007). To keep a good oral hygiene, it is very important to check the growth of S. mutans. However, over and unwarranted use of antibiotics has also resulted in the development of antibiotic resistance in these pathogens (Leistevuo et al. 2000). Since, thymol and carvacrol exhibit good antimicrobial activity these essential oils were purified from O. vulgare L. and their antimicrobial activity against S. mutans was determined. Furthermore, the antimicrobial activity of thymol and carvacrol was compared with clove oil, a traditionally used essential oil in dentistry, and with chlorhexidine digluconate a widely used compound in mouthwashes (McBain et al. 2003; Thosar et al. 2013). To our knowledge, this is the first such detailed report on the antimicrobial and antibiofilm activity of thymol and carvacrol against S. mutans.

IC50 values of thymol, carvacrol, clove oil and chlorhexidine digluconate were found to be 54, 65, 306 and 4.9 µg/ml, respectively in this study. These results were further confirmed by MTT assay wherein 200 µg/ml of thymol and carvacrol reduced the cell viability by 87 ± 6 and 74 ± 8%, respectively. While, chlorhexidine digluconate resulted in the death of 37 ± 3% of the cells at a very low concentration of 2.5 µg/ml. In earlier studies, the essential oils from thyme and origanum exhibited high MIC values in a range of 256–512 μg/ml against group A Streptococci (GAS) (Magi et al. 2015). While in the same study commercially available carvacrol exhibited a MIC value in the range of 64–256 µg/ml against GAS (Magi et al. 2015). Decontamination of lettuce using a solution of carvacrol and thymol was also reported since these essential oils are edible (Bagamboula et al. 2004). In another study, the antimicrobial activity of microencapsulated carvacrol and thymol was determined against many microorganisms including foodborne pathogens Escherichia coli O157:H7, Staphylococcus aureus, and Listeria innocua. The MIC of the microencapsulated carvacrol and thymol against these organisms were in the range of 225–375 ppm (Guarda et al. 2011). The positive control chlorhexidine digluconate suppressed the growth and viability of S. mutans at much lower concentrations as found in earlier studies also (McBain et al. 2003). While, the MIC values of eugenol a main constiuent of clove oil against S. mutans were reported to be 100 µg/ml (Freires et al. 2015).

As far as the mechanism of the antimicrobial activity is concerned, it is suggested that these compounds are involved in the permeabilization and depolarization of the cytoplasmic membrane. Which results in the reduction of the pH gradient across the cytoplasmic membrane. This lowering of pH gradient leads to the disturbance in proton motive force subsequently leading to the depletion of intracellular ATP level and cell death (Ultee et al. 2002). The increase in the number of dead cells following the treatment with thymol and carvacrol was also observed in this study (Figs. 3b, 4) through propidium iodide staining a dye that can only penetrate into the cells having compromised cell wall. Deformed and lysed cells as observed under scanning electron microscope further confirms that thymol and carvacrol results in the lysis of the cells. The overexpression of autolysin genes involved in the restructuring of the cell wall further confirms these findings. Our results also show the over expression sodA and ymcA genes, suggesting that treatment with thymol and carvacrol induces general and oxidative stress in the cells. Chlorhexidine digluconate also exhibit its antimicrobial activity primarily through membrane disruption (McBain et al. 2003). Inhibition of glycosidic and proteolytic enzymes by chlorhexidine digluconate is also reported (Hastings 2000). Although carvacrol and thymol also disrupt the cell membrane but these essential oils are not water-soluble which may adversely affect their penetration into the bacterial cells resulting in lower activity. This argument is also supported by the findings that nano form of thymol exhibit better antimicrobial activity than the native form because of the improved dispersibility (Shah et al. 2012).

Another important trait of pathogenicity is biofilm formation. Biofilms exhibit greater resistance to antimicrobial agents and are difficult to treat (Ahn et al. 2008; Curtis et al. 2011). Therefore, the antibiofilm activities of carvacrol (M-1) and thymol (M-2) against S. mutans was determined. The results of crystal violet assay and the qualitative examination of the biofilms under SEM (Fig. 6) suggest that the two compounds significantly reduce the biofilm formation by S. mutans. In gene expression studies also the downregulation of glycosyl transferase B (gtfB) gene suggests the inhibition of biofilm formation. Previously the antibiofilm activity of thymol and carvacrol against Pseudomonas aeruginosa has been reported (Ceylan and Ugur 2015). Chlorhexdine digluconate also reduced the biofilm formation at a concentration of 10 µg/ml. Inhibition of biofilm formation by chlorhexidine has been reported in in vivo studies also (Bailón-Sánchez et al. 2014). As far as the antimicrobial and antibiofilm activities of clove oil are concerned clove oil was found to be least effective.

Results presented in this study strongly suggest that thymol and carvacrol exhibit significant antimicrobial and antibiofilm activities against S. mutans. Since these compounds are derived from edible plants classified as GRAS, these essential oils can be used in mouthwashes or toothpastes for controlling oral bacteria and for maintaining good oral hygiene. Furthermore, unlike chlorhexidine digluconate, thymol and carvacrol have some health benefits in addition to the desired antimicrobial activity. Although, chlorhexidine digluconate is widely used and do not have any known health hazard but its effect on taste buds is well known (Helms et al. 1995).

Authors’ contributions

STK, main author designed and executed the study. MK, he collected the plant sample and isolated and identified thymol and carvacrol therefrom. JA, he did RNA isolation and RT-PCR studies. RW, he helped in microbiological studies. OHAE carried out the SEM studies. JM, HZA and AAAK, arranged funding and helped in preparing the manuscript. All authors read and approved the final manuscript.

Acknowledgements

Authors would like to thank Twasol Research Excellence Program (TRE Program), King Saud University, Saud Arabia for support.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All the data are provided as an excel sheet except for the data on purification and characterization of carvacrol and thymol that will be published elsewhere.

Ethical statement

This article does not contain any studies with human participants or animals performed by any of the authors.

Abbreviations

µg

microgram

µl

microliter

ml

milliliter

nm

nanometer

CAR (M-1)

carvacrol

THY (M-2)

thymol

CHD

chlorhexidine digluconate

MTT

(3-(4, 5-Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium Bromide)

RT-PCR

real time PCR

sodA

super oxide dismutase A

gtf

glucosyltransferase

Atl

N-acetylmuramoyl-l-alanine amidase type

ATCC

American Type Culture Collection

BHI

brain heart infusion broth

°C

degree centigrade

%

percent

CFU

colony-forming unit

h

hour

d

day

s

seconds

rpm

revolutions per minute

PBS

phosphate-buffered saline

OsO4

osmium tetroxide

PCR

polymerase chain reaction

cDNA

complementary DNA

IC50

inhibitory concentration

GC–MS

gas chromatography mass spectrometry

GC–FID

gas chromatography—flame ionization detector

NMR

nuclear magnetic resonance spectroscopy

MIC

minimum inhibitory concentration

ATP

adenosine triphosphate

GRAS

generally recognized as safe

Additional file

13568_2017_344_MOESM1_ESM.xlsx (18.5KB, xlsx)

Additional file 1. Raw data obtained during this study.

Contributor Information

Shams Tabrez Khan, Phone: +966-11-4674339, Email: shamsalig75@gmail.com.

Merajuddin Khan, Email: mdk.chem@gmail.com.

Javed Ahmad, Email: javedbiochem@gmail.com.

Rizwan Wahab, Email: rizwanano@gmail.com.

Omar H. Abd-Elkader, Email: omabdelkader7@gmail.com

Javed Musarrat, Email: musarratj1@yahoo.com.

Hamad Z. Alkhathlan, Phone: +966-11-4675910, Email: khathlan@ksu.edu.sa

Abdulaziz A. Al-Kedhairy, Email: kedhairy@ksu.edu.sa

References

  1. Ahn SJ, Burne RA. The atlA operon of Streptococcus mutans: role in autolysin maturation and cell surface biogenesis. J Bacteriol. 2006;188:6877–6888. doi: 10.1128/JB.00536-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahn SJ, Wen ZT, Brady LJ, Burne RA. Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva. Infect Immun. 2008;76:4259–4268. doi: 10.1128/IAI.00422-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ajdić D, McShan WM, McLaughlin RE, Savić G, Chang J, Carson MB, Primeaux C, Tian R, Kenton S, Jia H, Lin S, Qian Y, Li S, Zhu H, Najar F, Lai H, White J, Roe BA, Ferretti JJ. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci USA. 2002;99:14434–14439. doi: 10.1073/pnas.172501299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Allen HK, Trachsel J, Looft T, Casey TA. Finding alternatives to antibiotics. Ann NY Acad Sci. 2014;1323:91–100. doi: 10.1111/nyas.12468. [DOI] [PubMed] [Google Scholar]
  5. Bagamboula CF, Uyttendaele M, Debevere J. Inhibitory effect of thyme and basil essential oils, carvacrol, thymol, estragol, linalool and p-cymene towards Shigella sonnei and S. flexneri. Food Microbiol. 2004;21:33–42. doi: 10.1016/S0740-0020(03)00046-7. [DOI] [Google Scholar]
  6. Bailón-Sánchez ME, Baca P, Ruiz-Linares M, Ferrer-Luque CM. Antibacterial and anti-biofilm activity of AH plus with chlorhexidine and cetrimide. J Endod. 2014;40:977–981. doi: 10.1016/j.joen.2013.11.020. [DOI] [PubMed] [Google Scholar]
  7. Burdock GA, Carabin IG. Generally recognized as safe (GRAS): history and description. Toxicol Lett. 2004;150:3–18. doi: 10.1016/j.toxlet.2003.07.004. [DOI] [PubMed] [Google Scholar]
  8. Burton E, Yakandawala N, LoVetri K, Madhyastha MS. A microplate spectrofluorometric assay for bacterial biofilms. J Ind Microbiol Biotechnol. 2007;34:1–4. doi: 10.1007/s10295-006-0086-3. [DOI] [PubMed] [Google Scholar]
  9. Carabetta VJ, Tanner AW, Greco TM, Defrancesco M, Cristea IM, Dubnau D. A complex of YlbF, YmcA and YaaT regulates sporulation, competence and biofilm formation by accelerating the phosphorylation of Spo0A. Mol Microbiol. 2013;88:283–300. doi: 10.1111/mmi.12186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ceylan O, Ugur A. Chemical composition and anti-biofilm activity of Thymus sipyleus BOISS. subsp. sipyleus BOISS. var. davisianus RONNIGER essential oil. Arch Pharm Res. 2015;38:957–965. doi: 10.1007/s12272-014-0516-0. [DOI] [PubMed] [Google Scholar]
  11. Chorianopoulos N, Kalpoutzakis E, Aligiannis N, Mitaku S, Nychas G-J, Haroutounian SA. Essential oils of Satureja, Origanum, and Thymus species: chemical composition and antibacterial activities against foodborne pathogens. J Agric Food Chem. 2004;52:8261–8267. doi: 10.1021/jf049113i. [DOI] [PubMed] [Google Scholar]
  12. Craig WJ. Health-promoting properties of common herbs. Am J Clin Nutr. 1999;70:491S–499S. doi: 10.1093/ajcn/70.3.491s. [DOI] [PubMed] [Google Scholar]
  13. Curtis MA, Zenobia C, Darveau RP. The relationship of the oral microbiotia to periodontal health and disease. Cell Host Microbe. 2011;10:302–306. doi: 10.1016/j.chom.2011.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG. The human oral microbiome. J Bacteriol. 2010;192:5002–5017. doi: 10.1128/JB.00542-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Du E, Gan L, Li Z, Wang W, Liu D, Guo Y. In vitro antibacterial activity of thymol and carvacrol and their effects on broiler chickens challenged with Clostridium perfringens. J Anim Sci Biotechnol. 2015;6:58. doi: 10.1186/s40104-015-0055-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Du E, Wang W, Gan L, Li Z, Guo S, Guo Y. Effects of thymol and carvacrol supplementation on intestinal integrity and immune responses of broiler chickens challenged with Clostridium perfringens. J Anim Sci Biotechnolo. 2016;7:19. doi: 10.1186/s40104-016-0079-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fachini-Queiroz FC, Kummer R, Estevão-Silva CF, Carvalho MD, Cunha JM, Grespan R, Bersani-Amado CA, Cuman RK. Effects of thymol and carvacrol, constituents of Thymus vulgaris L. essential oil, on the inflammatory response. Evid Based Complement Alternat Med. 2012 doi: 10.1155/2012/657026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Freires IA, Denny C, Benso B, de Alencar SM, Rosalen PL. Antibacterial activity of essential oils and their isolated constituents against cariogenic bacteria: a systematic review. Molecules. 2015;20:7329–7358. doi: 10.3390/molecules20047329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Guarda A, Rubilar JF, Miltz J, Galotto MJ. The antimicrobial activity of microencapsulated thymol and carvacrol. Int J Food Microbiol. 2011;146:144–150. doi: 10.1016/j.ijfoodmicro.2011.02.011. [DOI] [PubMed] [Google Scholar]
  20. Guarda A, Rubilar JF, Miltz J, Galotto MJ. The antimicrobial activity of microencapsulated thymol and carvacrol. Int J Food Microbiol. 2011;146:144–150. doi: 10.1016/j.ijfoodmicro.2011.02.011. [DOI] [PubMed] [Google Scholar]
  21. Hastings DC. Non-antibiotic plaque chemotherapy. In: Newman HN, Wilson M, editors. Dental plaque revisited: oral biofilms in health and disease. Cardiff: Bioline Press; 2000. pp. 523–548. [Google Scholar]
  22. Helms JA, Della-Fera MA, Mott AE, Frank ME. Effects of chlorhexidine on human taste perception. Arch Oral Biol. 1995;40:913–920. doi: 10.1016/0003-9969(95)00062-T. [DOI] [PubMed] [Google Scholar]
  23. Hyldgaard M, Mygind T, Meyer RL. Essential oils in food preservation: mode of action, synergies, and interactions with food matrix components. Front Microbiol. 2012;3:12. doi: 10.3389/fmicb.2012.00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kalemba D, Kunicka A. Antibacterial and antifungal properties of essential oils. Curr Med Chem. 2003;10:813–829. doi: 10.2174/0929867033457719. [DOI] [PubMed] [Google Scholar]
  25. Khan ST, Al-Khedhairy AA, Musarrat J. ZnO and TiO2 nanoparticles as novel antimicrobial agents for oral hygiene: a review. J Nanopart Res. 2015;17:276. doi: 10.1007/s11051-015-3074-6. [DOI] [Google Scholar]
  26. Khan M, Al-Saleem MSM, Alkhathlan HZ. A detailed study on chemical characterization of essential oil components of two Plectranthus species grown in Saudi Arabia. J Saudi Chem Soci. 2016;20:711–721. doi: 10.1016/j.jscs.2016.03.006. [DOI] [Google Scholar]
  27. Khan ST, Ahmad J, Ahamed M, Musarrat J, Al-Khedhairy AA. Zinc oxide and titanium dioxide nanoparticles induce oxidative stress, inhibit growth, and attenuate biofilm formation activity of Streptococcus mitis. J Biol Inorg Chem. 2016;21:295–303. doi: 10.1007/s00775-016-1339-x. [DOI] [PubMed] [Google Scholar]
  28. Khan ST, Musarrat J, Al-Khedhairy AA. Countering drug resistance, infectious diseases, and sepsis using metal and metal oxides nanoparticles: current status. Coll Surf B Biointerfaces. 2016;146:70–83. doi: 10.1016/j.colsurfb.2016.05.046. [DOI] [PubMed] [Google Scholar]
  29. Klein MI, Hwang G, Santos PHS, Campanella OH, Koo H. Streptococcus mutans-derived extracellular matrix in cariogenic oral biofilms. Front Cell Infect Microbiol. 2015 doi: 10.3389/fcimb.2015.00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kojima A, Nakano K, Wada K, Takahashi H, Katayama K, Yoneda M, Higurashi T, Nomura R, Hokamura K, Muranaka Y, Matsuhashi N, Umemura K, Kamisaki Y, Nakajima A, Ooshima T. Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci Rep. 2012;2:332. doi: 10.1038/srep00332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Krzyściak W, Jurczak A, Kościelniak D, Bystrowska B, Skalniak A. The virulence of Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis. 2014;33:499–515. doi: 10.1007/s10096-013-1993-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Leistevuo J, Järvinen H, Österblad M, Leistevuo T, Huovinen P, Tenovuo J. Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrob Agents Chemother. 2000;44:456–457. doi: 10.1128/AAC.44.2.456-457.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000;13:547–558. doi: 10.1128/CMR.13.4.547-558.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Listl S, Galloway J, Mossey PA, Marcenes W. Global economic impact of dental diseases. J Dent Res. 2015;94:1355–1361. doi: 10.1177/0022034515602879. [DOI] [PubMed] [Google Scholar]
  35. Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev. 1986;50:353–380. doi: 10.1128/mr.50.4.353-380.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Magi G, Marini E, Facinelli B. Antimicrobial activity of essential oils and carvacrol, and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant Group A Streptococci. Front Microbiol. 2015;6:165. doi: 10.3389/fmicb.2015.00165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Gilbert P. Effects of a chlorhexidine gluconate-containing mouthwash on the vitality and antimicrobial susceptibility of in vitro oral bacterial ecosystems. Appl Environ Microbiol. 2003;69:4770–4776. doi: 10.1128/AEM.69.8.4770-4776.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Moore WEC, Moore LVH. The bacteria of periodontal diseases. Periodontology. 1994;2000(5):66–77. doi: 10.1111/j.1600-0757.1994.tb00019.x. [DOI] [PubMed] [Google Scholar]
  39. Mshana RN, Tadesse G, Abate G, Miorner H. Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol. 1998;36:1214–1219. doi: 10.1128/jcm.36.5.1214-1219.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nobbs A. Getting to the heart of the matter: role of Streptococcus mutans adhesin Cnm in systemic disease. Virulence. 2016 doi: 10.1080/21505594.2016.1212157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nostro A, Papalia T. Antimicrobial activity of carvacrol: current progress and future prospectives. Recent Pat Antiinfect Drug Discov. 2012;7:28–35. doi: 10.2174/157489112799829684. [DOI] [PubMed] [Google Scholar]
  42. Robbins N, Szilagyi G, Tanowitz HB, Luftschein S, Baum SG. Infective endocarditis caused by Streptococcus mutans. A complication of idiopathic hypertrophic subaortic stenosis. Arch Intern Med. 1977;137:1171–1174. doi: 10.1001/archinte.1977.03630210045014. [DOI] [PubMed] [Google Scholar]
  43. Rose T, Verbeken G, Vos DD, Merabishvili M, Vaneechoutte M, Lavigne R, Jennes S, Zizi M, Pirnay JP. Experimental phage therapy of burn wound infection: difficult first steps. Int J Burns Trauma. 2014;4:66–73. [PMC free article] [PubMed] [Google Scholar]
  44. Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet. 2007;369:51–59. doi: 10.1016/S0140-6736(07)60031-2. [DOI] [PubMed] [Google Scholar]
  45. Shah B, Davidson PM, Zhong Q. Nanocapsular dispersion of thymol for enhanced dispersibility and increased antimicrobial effectiveness against Escherichia coli O157:H7 and Listeria monocytogenes in model food systems. Appl Environ Microbiol. 2012;78:8448–8453. doi: 10.1128/AEM.02225-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sweeney LC, Dave J, Chambers PA, Heritage J. Antibiotic resistance in general dental practice–a cause for concern? J Antimicrob Chemother. 2004;53:567–576. doi: 10.1093/jac/dkh137. [DOI] [PubMed] [Google Scholar]
  47. Thosar N, Basak S, Bahadure RN, Rajurkar M. Antimicrobial efficacy of five essential oils against oral pathogens: an in vitro study. Eur J Dent. 2013;7:S71–S77. doi: 10.4103/1305-7456.119078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 2002;34:1524–1529. doi: 10.1086/340402. [DOI] [PubMed] [Google Scholar]
  49. Ultee A, Bennik MH, Moezelaar R. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl Environ Microbiol. 2002;68:1561–1568. doi: 10.1128/AEM.68.4.1561-1568.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wade WG. The oral microbiome in health and disease. Pharmacol Res. 2013;69:137–143. doi: 10.1016/j.phrs.2012.11.006. [DOI] [PubMed] [Google Scholar]
  51. Xu J, Zhou F, Ji BP, Pei RS, Xu N. The antibacterial mechanism of carvacrol and thymol against Escherichia coli. Lett Appl Microbiol. 2008;47:174–179. doi: 10.1111/j.1472-765X.2008.02407.x. [DOI] [PubMed] [Google Scholar]
  52. Yamamoto Y, Higuchi M, Poole LB, Kamio Y. Role of the dpr product in oxygen tolerance in Streptococcus mutans. J Bacteriol. 2000;182:3740–3747. doi: 10.1128/JB.182.13.3740-3747.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All the data are provided as an excel sheet except for the data on purification and characterization of carvacrol and thymol that will be published elsewhere.


Articles from AMB Express are provided here courtesy of Springer-Verlag

RESOURCES